1. Home
  2. RYTM vs TKR Comparison

RYTM vs TKR Comparison

Compare RYTM & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • TKR
  • Stock Information
  • Founded
  • RYTM 2008
  • TKR 1899
  • Country
  • RYTM United States
  • TKR United States
  • Employees
  • RYTM N/A
  • TKR N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • TKR Metal Fabrications
  • Sector
  • RYTM Health Care
  • TKR Industrials
  • Exchange
  • RYTM Nasdaq
  • TKR Nasdaq
  • Market Cap
  • RYTM 6.4B
  • TKR 5.4B
  • IPO Year
  • RYTM 2017
  • TKR N/A
  • Fundamental
  • Price
  • RYTM $97.86
  • TKR $76.76
  • Analyst Decision
  • RYTM Strong Buy
  • TKR Buy
  • Analyst Count
  • RYTM 13
  • TKR 11
  • Target Price
  • RYTM $109.77
  • TKR $80.60
  • AVG Volume (30 Days)
  • RYTM 627.7K
  • TKR 672.3K
  • Earning Date
  • RYTM 11-04-2025
  • TKR 11-04-2025
  • Dividend Yield
  • RYTM N/A
  • TKR 1.83%
  • EPS Growth
  • RYTM N/A
  • TKR N/A
  • EPS
  • RYTM N/A
  • TKR 4.40
  • Revenue
  • RYTM $156,287,000.00
  • TKR $4,514,100,000.00
  • Revenue This Year
  • RYTM $46.10
  • TKR N/A
  • Revenue Next Year
  • RYTM $60.39
  • TKR $3.14
  • P/E Ratio
  • RYTM N/A
  • TKR $17.40
  • Revenue Growth
  • RYTM 53.55
  • TKR N/A
  • 52 Week Low
  • RYTM $45.91
  • TKR $56.20
  • 52 Week High
  • RYTM $106.52
  • TKR $87.52
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 49.11
  • TKR 51.26
  • Support Level
  • RYTM $95.88
  • TKR $74.11
  • Resistance Level
  • RYTM $102.79
  • TKR $76.25
  • Average True Range (ATR)
  • RYTM 3.20
  • TKR 1.54
  • MACD
  • RYTM -0.25
  • TKR -0.00
  • Stochastic Oscillator
  • RYTM 32.99
  • TKR 46.74

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.

Share on Social Networks: